According to a new survey by the People’s Vaccine Alliance, most people in G countries believe that the government needs to ensure that drug companies share their vaccine formulas and technologies.
In a briefing on Wednesday, the coalition said the G-countries wanted an average of seven out of 10 people across the country to ensure that the government shared knowledge of the vaccine.
Respondents were asked if they believed that pharmaceutical companies should pay fair compensation for developing vaccines, but should not be exclusive to vaccines.
A total of 4% of people in the UK want a political monopoly to be resisted, with people from all political backgrounds supporting the intervention.
Support for government intervention was highest in 62 percent of respondents in Italy, followed by Canada where 76 percent agreed.
In the United States, 699 percent of the population supports the measure, while 56 percent in Japan agree with it.
According to the survey, the member states of the European Union are also in favor with the support of 100% in Germany and 633% in France.
The poll was released as members of the G7 in London on Wednesday, the final day of formal talks. G-members, comprising the United Kingdom, the United States, Japan, France, Germany, Canada and Italy, will try to agree on a long-term coronavirus vaccine supply worldwide.
On Tuesday, British Prime Minister Boris Johnson and US Secretary of State Anthony Blinken agreed on the need for a global Covid-19 vaccine to stop the epidemic.
“Prime Minister and Secretary Blinken have agreed that vaccines worldwide will be the key to overcoming the coronavirus epidemic,” Johnson’s office said in a statement. “They emphasized the importance of G7 work in this area, including efforts to increase international production capacity.”
Separately on Wednesday, the World Trade Organization (WTO) will hold a remote meeting, where members will discuss proposals to waive intellectual property rights to make coronavirus vaccines for the duration of the epidemic.
Sponsors of the plan, originally submitted by South Africa and India, argued that it would allow more space to develop the coronavirus vaccine without violating international rules under the WTO’s Intellectual Property Rights (TRPS) agreement.
But countries including the United States, the United Kingdom, Japan, Canada and the EU have blocked the proposal. The US has confirmed this To reconsider the opposition to the waiver.
Pharmaceutical companies have so far refused to share how they know their vaccines, arguing that any leaks would harm innovation.
The WTO meeting came as India struggled to fight the devastating second wave of coronavirus, leaving breathless hospitals and clinics in a state of shock amid a lack of medical oxygen and beds.
The world’s second most populous country has confirmed more than that 20 million infectionsAlthough this figure is believed to be a huge undercountry. More than 220,000 people died.
Some experts believe that the increase, driven by new forms of the virus, including the first one discovered in India, has resulted in the deaths of patients suffering in ambulances and car parks.
According to the WHO, the Indian version has so far spread to 17 countries.
“The dire situation in India should lead G7 leaders to their core,” Sawyers Fitzpatrick, advocacy manager for StopAids, said in a statement.
“Now is not the time for ideological defense of intellectual property laws. Bilateral agreements with pharmaceutical companies have not been implemented. Governments need to take action and pharmaceutical companies need to be told how to communicate their intellectual property and vaccines to the world. “
As the G7 chair, the UK has proposed an epidemic preparedness plan, which will be discussed by ministers this week, ignoring the issue of exclusive and intellectual property. Amnesty says pharmaceutical corporations like Pfizer are on the proposal-making team, but developing country governments and vaccine manufacturers have not been asked to join, Amnesty said.
“The G7 governments have a clear human rights obligation to protect the lives of millions of people around the world, rather than the interests of drug companies,” said Steve Cockburn, head of economic and social justice at Amnesty International.
“Continuing to share life-saving technology will be the ultimate failure of leadership and will only prolong the enormous amount of pain and suffering caused by this epidemic.”
In April, 175 former world leaders and Nobel laureates, including Gordon Brown, Ellen Johnson Sirleaf and Franইois Hollande An open letter, US President Joe Biden called for support Temporary waiver of intellectual property rights For the COVID-19 vaccine.
Leading health experts around the world have warned that slow and uneven distribution of vaccines could be the cause. Vaccine shots will become ineffective As new coronavirus mutations appear in isolated populations.
The Independent SAJO, an independent public health consultancy in the UK, has also called for the patent to be waived.
Drug companies that produce the coronavirus vaccine have received ফ 12 billion in public funding and guaranteed pre-orders from the U.S. government alone. Amphosti said 97 percent of the estimated funding for the Oxford-Astragenica vaccine came from public sources.
“Companies have paid a combined এই 28 billion in dividends and stock buybacks to their shareholders this year, enough to vaccinate at least 1.3 billion people, equivalent to Africa’s population.”